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Objectives. We sought to examine the hypothesis that rapid
resolution of ST-segment elevation in acute myocardial infarction
(AMI) patients with early peak creatine kinase (CK) after throm-
bolytic therapy differentiates among patients with early recanali-
zation between those with and those without adequate tissue
(myocardial) reperfusion.
Background. Early recanalization of the epicardial infarct-
related artery (IRA) during AMI does not ensure adequate
reperfusion on the myocardial level. While early peak CK after
thrombolysis results from early and abrupt restoration of the
coronary flow to the infarcted area, rapid ST-segment resolution,
which is another clinical marker of successful reperfusion, reflects
changes of the myocardial tissue itself.
Methods. We compared the clinical and the angiographic
results of 162 AMI patients with early peak CK (<212 h) after
thrombolytic therapy with (group A) and without (group B)
concomitant rapid resolution of ST-segment elevation.
Results. Patients in groups A and B had similar patency rates
of the IRA on angiography (anterior infarction: 93% vs. 93%;
inferior infarction: 89% vs. 77%). Nevertheless, group A versus B
patients had lower peak CK (anterior infarction: 1,083 6
585 IU/ml vs. 1,950 6 1,216, p < 0.01; and inferior infarction:
940 6 750 IU/ml vs. 1,350 6 820, p 5 0.18) and better left
ventricular ejection fraction (anterior infarction: 49 6 8, vs. 44 6
8, p < 0.01; inferior infarction: 56 6 12 vs. 51 6 10, p 5 0.1). In
a 2-year follow-up, group A as compared with group B patients
had a lower rate of congestive heart failure (1% vs. 13%, p < 0.01)
and mortality (2% vs. 13%, p < 0.01).
Conclusions. Among patients in whom reperfusion appears to
have taken place using an early peak CK as a marker, the
coexistence of rapid resolution of ST-segment elevation further
differentiates among patients with an opened culprit artery be-
tween the ones with and without adequate myocardial reperfusion.
(J Am Coll Cardiol 1998;32:1326–30)
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Early reperfusion of the infarct-related artery (IRA) remains
the most effective treatment for acute myocardial infarction
(AMI). However, even early restoration of flow in the IRA
does not assure adequate reperfusion of the myocardial tissue
(1–4). Scintigraphic (1,2) and contrast echocardiographic (3,4)
studies have shown that as many as 25% of the patients with
angiographically successful thrombolysis lacked myocardial
reperfusion, and failed thereafter to improve myocardial func-
tion (3,4).
After thrombolytic therapy, early and rapid resolution of
ST-segment elevation (5–10) and early peaking of creatine
kinase (CK) (8,11–14) are considered markers of successful
reperfusion. However, while the early peak CK results from
the abrupt washout of the previously occluded IRA and its
related vasculature (3,15–17), the resolution of ST-segment
elevation reflects the changes in the jeopardized myocardium
itself (18). We hypothesized that absence of concordance
between these two nonangiographic markers of reperfusion
(early peak CK but without early resolution of ST-segment
elevation) discloses a dissociation between reperfusion on the
vascular (coronary) and tissue (myocardial) level. To examine
this hypothesis we compared the outcome of patients with
AMI who had early peak CK after thrombolytic therapy with
and without concomitant early resolution of ST-segment ele-
vation.
Methods
Study patients and study design. The study population
consisted of 220 consecutive patients with AMI who were
treated with recombinant tissue plasminogen activator within
4 h of the onset of symptoms. Acute myocardial infarction was
diagnosed based on a history of typical chest pain lasting
$30 min and ST-segment elevation of 1 mm or more in at least
two contiguous leads.
Patients with complete left bundle branch block (CLBBB)
on admission electrocardiogram (ECG) were excluded. In
each patient CK level was determined on admission, every 3 h
during the first 24 h, and once daily thereafter.
From the Heart Institute, Sheba Medical Center, Tel-Hashomer and Sackler
Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Manuscript received February 19, 1998; revised manuscript received June 10,
1998, accepted June 22, 1998.
Address for correspondence: Dr. Hanoch Hod, Heart Institute, Sheba
Medical Center, Tel-Hashomer 52621, Israel. E-mail: babethr@post.tau.ac.il.
JACC Vol. 32, No. 5
November 1, 1998:1326–30
1326
©1998 by the American College of Cardiology 0735-1097/98/$19.00
Published by Elsevier Science Inc. PII S0735-1097(98)00417-3
Early peak CK (within the first 12 h) was found in 168
patients. Fifty-one patients had late peak CK; and in one
patient the peak CK could not be determined due to a
technical problem. From the original cohort of 168 patients
with early peak CK, 6 patients were excluded: 4 underwent
rescue percutaneous transluminal coronary angiography
(PTCA) within the first hours; in 1 patient complete left bundle
branch block developed after inclusion; and in another patient,
the ECG recording was not adequate for analysis of ST-
segment changes. The aggregate ST-segment elevations
(S ST1) in the three contiguous leads showing the highest
initial ST-segment elevation were calculated in two ECGs: one
immediately before the administration of thrombolytic therapy
and the other 2 h later. Postthrombolysis early resolution of
ST-segment elevation was defined as a decrease of at least 50%
in the S ST1 between the two ECGs. The changes in S ST1
were evaluated independently and blindly by two investigators.
The patients with early CK were divided into two groups based
on the presence or the absence of early resolution of ST-
segment elevation.
Radionuclide assessment of left ventricular function. Left
ventricular ejection fraction (LVEF) was evaluated with rest
multigated equilibrium blood pool scan performed in the 45°
left anterior oblique projection. Global left ventricular func-
tion was assessed at discharge and 2, 6 and 12 months later.
Coronary angiography. Of the 162 patients, 125 consecu-
tive patients underwent coronary angiography within 96 h. The
perfusion status of the IRA was assessed using the Thrombol-
ysis In Myocardial Infarction (TIMI) criteria for reperfusion,
and the artery was considered patent when TIMI perfusion
flow 2 or 3 was established. Thereafter, the number of coronary
arteries with significant ($50%) stenosis was determined.
Clinical follow-up. The patients were followed up during
their hospitalization for any cardiac adverse event and for 2
years after their discharge through repeated visits to our
outpatient clinic at intervals of 2, 6, 12 and 24 months. For the
comparison of the clinical outcome, we specified in the present
study a combined clinical end point of congestive heart failure
and/or mortality which have a good clinical correlation with the
extent of myocardial damage.
Statistical analysis. In the comparison of patients with
ST-segment elevation resolution with those without, continu-
ous variables are presented as mean 6 SD and the differences
are assessed by standard t test. Discrete variables are presented
as numbers of patients or percentage, and differences are
assessed by chi square or Fisher’s exact test.
Results
Of the 162 patients with early peak CK who comprise the
subject of the present study, 71 had anterior infarct and 91 had
inferior infarct. While among the patients with anterior infarct,
35 (49%) had early resolution of ST-segment elevation; 73
(80%) with inferior infarct had early resolution. Thus, while
among the patients with early ST-segment resolution, 32% had
anterior AMI and 68% inferior AMI; among those without
early ST-segment resolution, 67% had anterior AMI and 33%
inferior AMI. Therefore, the results are being presented
according to infarct site.
The baseline characteristics of the patients are shown in
Table 1. Patients with and without rapid resolution of ST-
segment elevation had similar baseline characteristics regard-
less of infarct site except for a trend toward earlier adminis-
tration of thrombolytic therapy in patients without early
resolution of ST-segment elevation, which reached statistical
significance in patients with anterior infarction.
Indices of infarct size and left ventricular function. Early
resolution of ST-segment elevation was associated with lower
peak CK of 1,083 6 888 versus 1,950 6 1,216 (p , 0.01) for
anterior and 940 6 750 versus 1,350 6 820 (p 5 0.18) for
inferior infarction. Patients with early ST-segment elevation
resolution also had significantly better left ventricular function
at discharge and throughout the follow-up period (Table 2).
Angiographic results. Fifty-seven of the 71 patients with
anterior infarction were subsequently catheterized. The late
patency rate was identical in patients with (28 of 30; 93%) and
without (25 of 27; 93%) early resolution of the ST-segment
elevation.
Among the 91 patients with inferior infarction, 68 were
catheterized, and again the late patency rate of the IRA did
not differ significantly between patients with (89%) and with-
out (77%) early resolution of ST-segment elevations (p 5
0.34). Multivessel coronary artery disease was demonstrated in
57% versus 37% (p 5 0.14) of anterior infarct patients with
Abbreviations and Acronyms
AMI 5 acute myocardial infarction
CK 5 creatine kinase
ECG 5 electrocardiography
IRA 5 infarct-related artery
LVEF 5 left ventricular ejection fraction
PTCA 5 percutaneous transluminal coronary
angiography
TIMI 5 Thrombolysis In Myocardial Infarction (trial)
Table 1. Baseline Characteristics
Early ST1 Resolution









Age (yr) 57 6 10 58 6 9 56 6 10 58 6 9
Female/male 7/28 6/30 12/61 4/14
Previous myocardial infarction
(% patients)
17 11 16 22
Time from symptoms to
therapy (min)
133 6 56 108 6 38* 143 6 50 123 6 51
Time to peak creatine kinase
(h)
7.0 7.0 7.0 7.3
*p 5 0.03.
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and without early resolution of ST-segment elevation, respec-
tively, and in 53% versus 64% in patients with inferior infarc-
tion with and without early ST-segment resolution.
Clinical course. There were no significant differences in
the in-hospital clinical course between patients with and
without rapid ST-segment resolution regardless of infarct site,
except for a higher rate of reinfarction in patients with anterior
infarct with as compared with those without rapid ST-segment
resolution (17% vs. 0%, p 5 0.01) (Table 3). However, at the
end of the 2-year follow-up period, patients with early resolu-
tion of ST-segment elevation had lower incidence of chronic
heart failure and mortality (Table 4) and significantly lower
prevalence of the combined end point of heart failure and/or
mortality whether they had anterior or inferior infarction: 3%
versus 19% (p 5 0.05) in patients with anterior and 3% versus
22% (p , 0.05) in patients with inferior infarct. The long-term
incidence of adverse events did not differ significantly between
patients with anterior and inferior infarct in patients with and
those without early ST-segment elevation resolution. Thus, we
present in Figure 1 the results of the comparison of patients
with and without rapid ST-segment resolution in the whole
study population (regardless of infarct site). Patients with rapid
ST-segment resolution had significantly lower incidence of
chronic heart failure (1% vs. 13%, p , 0.01) and mortality (2%
vs. 13%, p , 0.01), although they had higher incidence of
reinfarction (27% vs. 9%, p 5 0.02).
Discussion
In the present study we found in a cohort of 162 patients
with AMI and early peak CK after thrombolytic therapy
concomitant rapid ST-segment elevation resolution only in
67% of the patients. Despite similar late (96 h) patency rate of
the IRA on angiography, the patients with rapid resolution of
ST-segment elevation as compared with those with early peak
CK but without rapid ST-segment elevation resolution bene-
fited more from thrombolysis judged from smaller enzymatic
infarct size, more preserved LVEF, and eventually better
long-term clinical outcome. These results suggest that in
patients with early peak CK, ST-segment resolution may
reflect myocardial reperfusion and salvage better than early
peak CK alone.
Comparison with previous studies of nonangiographic
signs of reperfusion. Although much has been written about
the reliability of early ST-segment resolution and early peak
CK to detect early reperfusion after thrombolytic therapy
(5–14), little is known about the relationship between these
two signs. Silber et al. (9) showed an improved LVEF and
survival in patients with early resolution of ST-segment eleva-
tion and early peak CK after thrombolysis as compared with
those with either one or none of these signs. It was also shown
that each, that is, early ST-segment resolution and early peak
CK, are independent predictors of infarct artery patency (8).
Our results are in strong agreement with those of van t’ Hof
et al. (18), who recently showed that rapid ST-segment eleva-
tion resolution after successful primary PTCA reflected myo-
cardial reperfusion rather than the restoration of flow in the
Table 2. Left Ventricular Function
LVEF
Early ST1 Resolution
Anterior MI Inferior MI
Present Absent p Value Present Absent p Value
Discharge 49 6 9 44 6 8 0.01 56 6 12 51 6 10 0.1
2 Months 50 6 11 45 6 9 0.04 60 6 11 54 6 9 0.04
6 Months 52 6 10 49 6 9 0.19 56 6 11 52 6 9 0.08
12 Months 53 6 9 47 6 10 0.01 59 6 10 53 6 11 0.03
MI 5 myocardial infarction.
Table 3. In-Hospital Clinical Outcome
Early ST1 Resolution









CHF 4 (11%) 2 (6%) 0 (0%) 1 (6%)
Reinfarction 6 (17%) 0 (0%)* 11 (15%) 4 (22%)
CABG 2 (6%) 1 (3%) 4 (5%) 1 (6%)
PTCA 18 (50%) 14 (39%) 29 (40%) 6 (33%)
Mortality 0 (0%) 2 (6%) 0 (0%) 1 (6%)
All results are presented as number of patients. *p 5 0.01. CABG 5
coronary artery bypass graft surgery; CHF 5 congestive heart failure; MI 5
myocardial infarction; PTCA 5 percutaneous transluminal coronary angioplasty.
Table 4. Long-Term (2-Year) Clinical Outcome
Early ST1 Resolution
Anterior MI Inferior MI
Present Absent Present Absent
Chronic CHF 1 (3%) 5 (14%) 0 (4%) 2 (11%)†
Reinfarction 10 (28%) 1 (3%)‡ 19 (26%) 4 (22%)
Revascularization
(PTCA or CABG)
24 (69%) 19 (53%) 39 (53%) 9% (50%)
Mortality 0 (0%) 4 (11%) 2 (3%) 3 (17%)*
CHF and/or mortality 1 (3%) 7 (19%)* 2 (3%) 4 (22%)†
*p 5 0.05; †p , 0.05; ‡p , 0.01. Abbreviations as in Table 3.
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IRA and was a predictor of the extent of myocardial damage
and of clinical outcome.
Possible mechanisms for the absence of ST-segment reso-
lution in patients with early peak CK. Few mechanisms might
be suggested for the absence of rapid resolution of ST-segment
elevation despite early peak CK and for the diminished
myocardial salvage in those patients:
(1) Previous studies showed that after thrombolytic therapy
(1–4) or direct PTCA (18–23), coronary reflow in the ischemic
myocardium might not have occurred despite early and ade-
quate reopening of the IRA. The “no-reflow” phenomenon is
due to microvascular dysfunction, which is caused by swelling
of the endothelial cells, perivascular edema, intramural hem-
orrhage, capillary plugging by erythrocytes and leukocytes, and
small vessels spasm (19,21,24–28). As a result of the inade-
quacy of the myocardial reperfusion, the no-reflow phenome-
non is associated with poor myocardial functional recovery
(3,4,29). The myocardium supplied by the reperfused IRA is
not uniformly affected by the no-reflow phenomenon (3,4,25),
and this phenomenon occurs to a variable extent in different
patients (1,3,4). Thus, while the areas of the jeopardized
myocardium with preserved microvasculature might account
for the early peak CK after restoration of flow in the IRA, the
extent of the jeopardized myocardium without effective reflow
due to microvasculature damage would determine the eventual
amount of myocardial salvage and whether concomitant rapid
resolution of ST-segment elevation occurs and to what extent.
This theoretical explanation agrees with previous studies
(19,21), which showed that the no-reflow phenomenon after
direct PTCA for AMI is associated with persistent ST-segment
elevation and myocardial damage despite the demonstration of
patent IRA, and that reversal of the no-reflow is associated
with resolution of the ST-segment elevation (21).
Kenner et al. (4) showed that the anterior, as opposed to
the inferior, myocardial infarcts were more prone to the
no-reflow phenomenon, supposedly due to the larger amount
of ischemic muscle and therefore higher wall stress and
regional oxygen demand and less collateral flow in the former
infarcts. Thus, this may explain our finding of higher preva-
lence of early resolution of ST-segment elevation among
patients with inferior as compared with those with anterior
myocardial infarcts.
(2) During acute ischemia the ST-segment elevation on the
surface ECG reflects the loss of resting membrane potential
and shortening of the plateau phase of the action potential in
the ischemic myocardium. Both changes are accounted for by
an increase in the extracellular potassium concentration, and
therefore, the washout of tissue potassium as a consequence of
successful reperfusion results in rapid resolution of ST-
segment elevation. Since the potassium ion is a smaller mole-
cule than CK, in patients with CK washout, as evidenced by
early peak CK, elevated extracellular potassium in areas that
were washed out may not account for persistent ST-segment
elevation. Previous experimental studies showed that peroxi-
dation of myocytes membrane lipids by oxidative stress might
lead to loss of resting membrane potential (30–32) and to
aberration of the action potential duration (30,32,33), which
are similar to the ones occurring as a result of ischemia.
Reperfusion of ischemic myocardium might be accompa-
nied by accelerated generation of oxygen-derived free radicals
and membrane lipids per oxidation (34,35). These radicals,
which play a major role in the pathogenesis of “reperfusion
injury,” might also account for persistent ST-segment elevation
despite rapid washout of the extracellular potassium along with
the CK accounting for the continued myocardial tissue injury.
Study limitation. The patients in the present study were
not catheterized immediately after the administration of
thrombolytic therapy, and differentiation between TIMI grade
II and III in the IRA was not made. Thus, one might claim that
the differences between the patients with and without early
resolution of ST-segment elevation lie in an earlier and/or
higher grade of vascular reperfusion. However, previous stud-
ies that did differentiate between TIMI grade II and III showed
that patients with TIMI grade II in early angiography did not
have an abrupt increase in plasma CK and had an enzyme
curve similar to the patients with TIMI 0 and I (36). Because
all the patients in the present study had early peak CK
differences in the epicardial coronary arteries, flow grade in the
IRA itself could not explain the findings of the present study.
Moreover, Kenner et al. (4) did not find any correlation
between the TIMI grade flow in the epicardial artery and the
occurrence of no-reflow as defined by contrast echocardiogra-
phy. It should be remembered that in patients with prior infarct
in the same site, persistent ST-segment elevation from the
previous infarct might interfere with the interpretation of
ST-segment changes.
Clinical implication. Although the immediate role of
thrombolytic therapy for AMI is early recanalization and
restoration of flow in the IRA, the eventual aim of all
reperfusion strategies is the achievement of adequate reperfu-
sion at the tissue level and thus myocardial salvage. However,
that might not occur even with early restoration of TIMI grade
III in the IRA (1–4). Therefore, early evaluation of the quality
of myocardial reperfusion might have important prognostic
value. In the present study among patients with an early peak
CK, which is considered as a marker of reperfusion, we
Figure 1. Comparison of long-term (2-year) clinical outcome of
patients with and without rapid ST-segment resolution. Open bars 5
patients with rapid ST1 resolution; solid bars 5 patients without
rapid ST1 resolution.
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observed that the presence or absence of rapid resolution of
ST-segment elevation differentiates between patients with
patent artery and improved myocardial perfusion (and better
clinical outcome) and patients with patent artery but without
successful myocardial reperfusion and worse prognosis and
outcome.
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